Vital Healthcare (VHP) announced 1) a 1H23 asset devaluation, 2) the pause of one of its low yielding development projects, 3) its first life sciences development, 4) NZ$200m of potential asset sales, and 5) the extension of its banking facilities
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.